# Temozolomide in Treating Patients With Progressive Low-Grade Glioma

> **NCT00003466** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 100 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00003466
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003466, "Temozolomide in Treating Patients With Progressive Low-Grade Glioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*